Lippo Cikarang Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lippo Cikarang Tbk trades at Rp510 (market cap 2.62T, 276.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Lippo Cikarang Tbk is far larger — about 15.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Lippo Cikarang Tbk is more actively traded (276.7K versus 96.7K). Which is the better fit depends on your goals.
| LPCK | OBAT | |
|---|---|---|
Market Cap | 2.62T | 167.37B |
Volume | 276.7K | 96.7K |
Lot | 2.77K | 967 |
Turnover | 143.99M | 23.82M |
Average Price | 520.38 | 246.34 |
Value | 143.99M | 23.82M |
Indicative Equilibrium Price | 510 | 248 |
Indicative Equilibrium Volume | 1 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Read more on LPCK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →